Literature DB >> 11218678

Fatal complications of systemic lupus erythematosus--an autopsy study from north India.

B Jindal1, K Joshi, B D Radotra, A K Banerjee.   

Abstract

Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disease with varied clinical manifestations and outcome. It may prove fatal due to disease activity or intercurrent infections. In recent years, earlier diagnosis and better treatment modalities have resulted in a change in the pattern of organ involvement and mode of death in the west. This aspect of the disease is unknown in India. Hence, in this autopsy series of SLE, the organ involvement and cause of death have been studied. Twenty five cases of clinically diagnosed SLE have been analysed retrospectively. Renal involvement was invariably present (96%) with class IV being the commonest lesion in 60% cases. Disease activity was noted in 60% cases. Pleuro pulmonary lesions were seen in 92% cases with infection being the commonest. Pulmonary infections included bacterial pneumonias (13), disseminated tuberculosis (3), pulmonary mucormycosis (1) and aspergillosis (1). Massive pulmonary haemorrhage in 5 cases and acute lupus pneumonitis in one, contributed to the demise of the patient. Vasculitis was evident in single organ in 9 cases, in two or more organs in 3 cases with systemic vasculitis significantly attributing to morbidity in 1 case. Active disease was the cause of death in 60% cases and infection in 40%.

Entities:  

Mesh:

Year:  2000        PMID: 11218678

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

1.  Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives.

Authors:  Neelufar Mozaffarian; Steve Lobosco; Peng Lu; Adam Roughley; Gabriela Alperovich
Journal:  Patient Prefer Adherence       Date:  2016-10-04       Impact factor: 2.711

Review 2.  Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature.

Authors:  Rajat Kharbanda; Anurag Mehndiratta; Rudrarpan Chatterjee; Rungmei S K Marak; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2021-10-04       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.